Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 4/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 3/20 | 0.40 |
| ▸ | CA5A | P35218 | 2/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | PEPD | P12955 | 1/20 | 0.36 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL5614383 | 0.96 | SLC34A1 (0.57) | LMNASLC34A1KMT2AKDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL29077434 | 0.96 | LMNA (0.47) | LMNASLC34A1KMT2AKDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL11356729 | 0.96 | LMNA (0.47) | LMNASLC34A1KMT2AKDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL28304761 | 0.93 | LMNA (0.44) | LMNASLC34A1KMT2AKDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL6070608 | 0.92 | SLC34A1 (0.61) | LMNASLC34A1KMT2AKDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL345051 | 0.92 | SLC34A1 (0.50) | LMNASLC34A1KMT2AKDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL27204660 | 0.92 | SLC34A1 (0.50) | LMNASLC34A1KMT2AKDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL28159823 | 0.92 | SLC34A1 (0.50) | LMNASLC34A1KMT2AKDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL980897 | 0.92 | SLC34A1 (0.61) | LMNASLC34A1KMT2AKDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL2908514 | 0.92 | SLC34A1 (0.50) | LMNASLC34A1KMT2AKDM4ECYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110711605-A | Active carbon carrier treatment method, preparation method and application of palladium-carbon catalyst | 西安凯立新材料股份有限公司 | 2020-01-21 | — | — | CN | claimed |
| CN-108707852-A | Bridge cable high intensity multiple zinc-base alloy coating wire and its hot plating technology | 江苏法尔胜缆索有限公司 | 2018-10-26 | — | — | CN | claimed |
| EP-3221342-A1 | SYNTHESIS OF GLP-1 PEPTIDES | Novetide Ltd. (IL) | 2017-09-27 | — | — | EP | claimed |
| WO-2016046753-A1 | SYNTHESIS OF GLP-1 PEPTIDES | NOVETIDE, LTD. (IL) | 2016-03-31 | — | — | WO | claimed |
| US-20240270889-A1 | GRAFT COPOLYMERS OF DEXTRAN AND POLYACRYLAMIDE AND METHODS OF MAKING AND USING SAME | FermWorx, LLC (US) | 2024-08-15 | — | — | US | disclosed |
| US-20240194304-A1 | Prediction Method, Prediction Device, and Prediction Program for New Indication of Desired Known Drug or Equivalent Material Thereof | KARYDO THERAPEUTIX, INC. (JP) | 2024-06-13 | — | — | US | disclosed |
| US-11999809-B2 | Graft copolymers of dextran and polyacrylamide and methods of making and using same | FermWorx, LLC (US) | 2024-06-04 | — | — | US | disclosed |
| US-20230399447-A1 | GRAFT COPOLYMERS OF DEXTRAN AND POLYACRYLAMIDE AND METHODS OF MAKING AND USING SAME | FermWorx, LLC (US) | 2023-12-14 | — | — | US | disclosed |
| CN-111074283-A | Cleaning method for laser loading box | 湖北三江航天红阳机电有限公司 | 2020-04-28 | — | — | CN | disclosed |
| CN-110711605-A | Active carbon carrier treatment method, preparation method and application of palladium-carbon catalyst | 西安凯立新材料股份有限公司 | 2020-01-21 | — | — | CN | disclosed |
| CN-110003482-A | A kind of polyacrylate dispersion and preparation method thereof towards plastic basis material | 常州大学 | 2019-07-12 | — | — | CN | disclosed |
| CN-108707852-A | Bridge cable high intensity multiple zinc-base alloy coating wire and its hot plating technology | 江苏法尔胜缆索有限公司 | 2018-10-26 | — | — | CN | disclosed |
| CN-1756571-A | Tissue reactive compounds and compositions and uses thereof | ANGIOTECH INTERNAT GMBH (CH) | 2006-04-05 | — | — | CN | disclosed |
| EP-1583561-A3 | TISSUE REACTIVE COMPOUNDS AND COMPOSITIONS AND USES THEREOF | ANGIOTECH INTERNATIONAL AG (CH) | 2005-12-07 | — | — | EP | disclosed |
| EP-1583561-A2 | TISSUE REACTIVE COMPOUNDS AND COMPOSITIONS AND USES THEREOF | ANGIOTECH INTERNATIONAL AG (CH) | 2005-10-12 | — | — | EP | disclosed |
| US-20040219214-A1 | Tissue reactive compounds and compositions and uses thereof | ANGIOTECH INTERNATIONAL AG (CH) | 2004-11-04 | — | — | US | disclosed |
| WO-2004060405-A2 | TISSUE REACTIVE COMPOUNDS AND COMPOSITIONS AND USES THEREOF | ANGIOTECH INTERNATIONAL AG (CH) | 2004-07-22 | — | — | WO | disclosed |
| US-5508342-A | INCORPORATED WITH UNSATURATED ACRYLATE PREFERABLY METHACRYLATE MONOMER SYSTEM, WHICH UPON POLYMERIZATION FORMS POLYMER OF SUFFICIENT PERMEABILITY TO PERMIT SLOW DIFFUSION OF MINERALS AND WATER TO TEETH AND BONES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF COMMERCE (US) | 1996-04-16 | — | — | US | disclosed |
| US-5128474-A | Herbicides | ISHIHARA SANGYO KAISHA LTD. (JP) | 1992-07-07 | — | — | US | disclosed |
| US-4211779-A | BACTERICIDES | SHIONOGI & CO., LTD. (JP) | 1980-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040219214-A1 | Tissue reactive compounds and compositions and uses thereof | CD44, SELP, EPCAM | LMNA 3608/4885SLC34A1 3125/4885KMT2A 4793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.